PR Newswire – n-Lorem

n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

SAN DIEGO, California and GENEVA, [...]

Andrew Andrew Serrano2026-01-12T16:23:50-04:00

n-Lorem Foundation receives $500,000 donation for providing experimental antisense medicines to treat patients with ultra-rare diseases

CARLSBAD, Calif., April 14, [...]

mikejaram2023-02-01T01:14:54-04:00

Korea Institute of Toxicology joins growing list of global partners supporting n-Lorem’s efforts to deliver treatments for patients with ultra-rare diseases

CARLSBAD, Calif., Mar [...]

mikejaram2023-02-01T01:15:07-04:00

n-Lorem Foundation receives additional support for providing “n of 1” experimental antisense medicines to treat patients with ultra-rare diseases

CARLSBAD, Calif., Mar [...]

mikejaram2023-02-01T01:15:16-04:00

n-Lorem Foundation established to charitably provide antisense medicines to treat patients with ultra-rare diseases

Foundation to custom [...]

mikejaram2023-02-01T01:15:40-04:00